🇺🇸 FDA

Company profile · Sponsor

Hipra

Hipra Human Health S.L.

E498A36 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Hipra (E498A36) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E498A36
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    Hipra

    COVID-19

    approved small molecule active

    1 trial

Frequently asked questions

What is Hipra?

Hipra (E498A36) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Hipra sponsor?

We track 1 ClinicalTrials.gov-linked program for Hipra, including BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted). Open each program for phase, modality, NCT IDs, and indication details.

Where does Hipra company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.